Efficacy of gefitinib ('Iressa', ZD1839) in a patient with advanced non-small-cell lung cancer with metastatic spread to the brain

被引：0
|
作者：
Petruzelka, L [1 ]
Zemanova, M [1 ]
机构：
[1] Charles Univ Prague, Univ Hosp, Prague, Czech Republic
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [21] Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
    Kakiuchi, S
    Daigo, Y
    Ishikawa, N
    Furukawa, C
    Tsunoda, T
    Yano, S
    Nakagawa, K
    Tsuruo, T
    Kohno, N
    Fukuoka, M
    Sone, S
    Nakamura, Y
    [J]. HUMAN MOLECULAR GENETICS, 2004, 13 (24) : 3029 - 3043
  • [22] Disease stabilisation following gefitinib ('Iressa', ZD1839) therapy in a patient with metastatic non-small-cell lung cancer and very poor performance status
    Vincent, MD
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S34 - S35
  • [23] Gefitinib ('Iressa', ZD1839) for patients with advanced non-small-cell lung cancer treated in the 'Iressa' Expanded Access Programme at a single institution in Brazil
    Katz, A
    Smaletz, O
    Simon, SD
    Rene, GC
    Hoff, PM
    Tabacof, J
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S29 - S29
  • [24] ZD1839 (Iressa™) in non-small cell lung cancer
    Herbst, RS
    Kies, MS
    [J]. ONCOLOGIST, 2002, 7 : 9 - 15
  • [25] Analysis of the efficacy and tolerability of gefitinib ('Iressa', ZD1839) in previously treated patients with non-small-cell lung cancer enrolled in the 'Iressa' Expanded Access Programme
    de Leeuw, K
    Schallier, D
    Sermijn, E
    Fontaine, C
    Neyns, B
    Samijn, I
    de Grève, J
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S28 - S28
  • [26] Commentary on ZD1839 (Iressa) in non small lung cancer
    Ranson, M
    Thatcher, N
    [J]. LUNG CANCER, 2003, 40 (01) : 77 - 78
  • [27] A case of diffuse interstitial pneumonitis in a patient with stage IV non-small-cell lung cancer receiving gefitinib ('Iressa', ZD1839) treatment
    Gervais, R
    Chasles, J
    Rivière, A
    Michels, JJ
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S28 - S29
  • [28] Activity of the epidermal growth factor receptor inhibitor gefitinib ('Iressa', ZD1839) in refractory non-small-cell lung cancer
    Parra, HS
    Cavina, R
    Zucali, P
    Campagnoli, E
    Latteri, F
    Biancofiore, G
    Abbadessa, G
    Morenghi, E
    Santoro, A
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S33 - S33
  • [29] Treatment of non-small-cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use programme
    Razis, Evangelia
    Skarlos, Dimosthenis V.
    Briassoulis, Evangelos
    Dimopoulos, Meletios
    Fountzilas, George
    Lambropoulos, Stefanos
    Rigatos, Sotiris
    Kopteridis, P.
    Efstathiou, Helen
    Kosmidis, Paris
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 183 - 183
  • [30] Activity of a specific inhibitor, gefitinib (Iressa™, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
    Santoro, A
    Cavina, R
    Latteri, F
    Zucali, PA
    Ginanni, V
    Campagnoli, E
    Ferrari, B
    Morenghi, E
    Pedicini, V
    Roncalli, A
    Alloisio, M
    Ravasi, G
    Parral, HJS
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (01) : 33 - 37
12345